March 27, 2017 09:44 AM EDT
Pharma

Am­gen trig­gers yet an­oth­er re­vamp, mov­ing re­searchers to two big hubs

John Carroll

Editor & Founder

Am­gen is once again re­struc­tur­ing its op­er­a­tions with plans to re­lo­cate, re­as­sign or ax about 500 jobs at its Thou­sand Oaks, CA head­quar­ters. The moves …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J takes 340B fight with fed­er­al gov­ern­ment to court

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times